REGENERON PHARMACEUTICALS, INC. (REGN) Balance sheet
Top 20 of 37 line items reported by REGN · 250+ in the full API →
REGENERON PHARMACEUTICALS, INC. (REGN) · Balance Sheet
Consolidated Balance Sheets
Quarterly · In millions USD · Latest as of Sep 30, 2026
| As of | ||||||
|---|---|---|---|---|---|---|
Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Trend | |
| Total Assets | $44,405.2 | $41,730.6 | $40,868.8 | $40,558.7 | $40,169.4 | |
| Total Current Assets | $20,795.1 | $18,446 | $18,209.2 | $18,021.9 | $17,980.7 | |
| Property, Plant & Equipment, net | 5,727.5 | 5,458.9 | 5,266.1 | 5,120.4 | 5,002.3 | |
| Operating leased assets | — | — | — | 246 | — | |
| Finance leased assets | — | — | — | 577 | — | |
| Intangible assets | 1,316 | 1,310 | 1,287 | 1,257 | 1,381 | |
| Other long-term assets | 2,474 | 2,306 | 2,130 | 1,821 | 1,673 | |
| Deferred tax assets, net | 4,536 | 4,381 | 4,191 | 4,077 | 3,847 | |
| Total Liabilities | $10,906.7 | $10,019.2 | $9,445.2 | $9,301.8 | $9,211.6 | |
| Total Current Liabilities | $6,202.1 | $5,530.6 | $5,107.7 | $4,368.4 | $4,425.1 | |
| Long-term debt | 1,987 | 1,987 | 1,986 | 1,986 | 1,986 | |
| Long-term unearned revenue | 220 | 220 | 225 | 209 | 219 | |
| Operating lease liabilities | — | — | — | 229 | — | |
| Long-term finance lease liabilities | 0 | 0 | 0 | 720 | 720 | |
| Other long-term liabilities | 2,497 | 2,282 | 2,126 | 2,019 | 1,862 | |
| Total Shareholders' Equity | $33,498.5 | $31,711.4 | $31,423.6 | $31,256.9 | $30,957.8 | |
| Current Ratio | 3.35 | 3.34 | 3.57 | 4.13 | 4.06 | |
| Quick Ratio | 2.72 | 2.63 | 2.84 | 3.28 | 3.19 | |
| Debt-to-Equity Ratio | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Working Capital | 14,593 | 12,915.4 | 13,101.5 | 13,653.5 | 13,555.6 | |
17 more line items available via the API
Cash & Short-Term InvestmentsCash & EquivalentsShort-Term InvestmentsAccounts ReceivableInventoryPrepaid expensesAccounts PayableAccrued LiabilitiesCurrent finance lease liabilitiesUnearned RevenueCommon StockAdditional paid-in capitalTreasury stock, at costRetained EarningsAccumulated other comprehensive incomeRestricted cash & equivalentsUnrecognized tax benefits
Ask your agent:
get_financialsAPIGET /api/v1/companies/REGN/balance-sheet?period=quarterly&years=2Docs →